• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉减少性肥胖患者心血管代谢风险增加:劳动者健康研究(ESAT)结果

Increased Cardiometabolic Risk in Dynapenic Obesity: Results from the Study of Workers' Health (ESAT).

作者信息

Carvalho Mariana de Oliveira, Duque Alice Pereira, Huguenin Grazielle Vilas Bôas, Felix Mediano Mauro Felippe, Rodrigues Júnior Luiz Fernando

机构信息

Education and Research Department, National Institute of Cardiology, Rio de Janeiro 22240-002, RJ, Brazil.

Nutrition and Dietetics Department, Fluminense Federal University, Niterói 24020-140, RJ, Brazil.

出版信息

Life (Basel). 2024 Sep 18;14(9):1174. doi: 10.3390/life14091174.

DOI:10.3390/life14091174
PMID:39337957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11433080/
Abstract

The coexistence of obesity and low muscle strength-denoted dynapenic obesity (DO)-has been associated with an unhealthy metabolic profile and increased risk for metabolic syndrome. However, there is a lack on studies investigating if DO exhibits higher cardiometabolic risk than non-dynapenic obesity. To assess if individuals with DO exhibit elevated cardiometabolic risk compared to non-dynapenic obesity. a cross-sectional study that analyzed the data of workers from a quaternary care hospital collected between November 2018 and March 2020. Participants were stratified into the following anthropometrical and peripheral muscle strength profiles: non-obese/non-dynapenic (NOND), non-obese/dynapenic (NOD), obese/non-dynapenic (OND), and obese dynapenic (OD). Cardiovascular risk was evaluated by Atherogenic Index (AI), Plasma Atherogenic Index (PAI), Hypertriglyceridemic Waist (HW), A Body Shape Index (ABSI), Atherogenic Dyslipidemia (AD), Castelli Indices I and II, and Framingham Score (FS). the OD group had significantly lower HDL compared to all others ( = 0.009), and despite exhibited lower prevalence of HW compared to OND ( < 0.01), a higher cardiometabolic risk compared to OND profile was observed assessing AI ( = 0.05), Castelli I ( < 0.05) and Castelli II ( < 0.05) scores. in the studied population, individuals with DO exhibit elevated cardiometabolic risk compared to other anthropometrical and peripheral muscle strength profiles.

摘要

肥胖与低肌肉力量并存(即肌无力性肥胖,DO),与不健康的代谢状况及代谢综合征风险增加有关。然而,缺乏研究来探究肌无力性肥胖是否比非肌无力性肥胖具有更高的心脏代谢风险。为评估与非肌无力性肥胖相比,肌无力性肥胖个体是否具有更高的心脏代谢风险,我们进行了一项横断面研究,分析了2018年11月至2020年3月期间从一家四级护理医院收集的工作人员数据。参与者被分为以下人体测量和外周肌肉力量类型:非肥胖/非肌无力(NOND)、非肥胖/肌无力(NOD)、肥胖/非肌无力(OND)和肥胖肌无力(OD)。通过致动脉粥样硬化指数(AI)、血浆致动脉粥样硬化指数(PAI)、高甘油三酯性腰围(HW)、体型指数(ABSI)、致动脉粥样硬化血脂异常(AD)、卡斯泰利指数I和II以及弗雷明汉评分(FS)来评估心血管风险。OD组的高密度脂蛋白水平显著低于其他所有组(P = 0.009),尽管与OND组相比HW患病率较低(P < 0.01),但在评估AI(P = 0.05)、卡斯泰利I(P < 0.05)和卡斯泰利II(P < 0.05)评分时,观察到OD组的心脏代谢风险高于OND组。在研究人群中,与其他人体测量和外周肌肉力量类型相比,肌无力性肥胖个体表现出更高的心脏代谢风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/395e/11433080/baadb44628a4/life-14-01174-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/395e/11433080/baadb44628a4/life-14-01174-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/395e/11433080/baadb44628a4/life-14-01174-g001.jpg

相似文献

1
Increased Cardiometabolic Risk in Dynapenic Obesity: Results from the Study of Workers' Health (ESAT).肌肉减少性肥胖患者心血管代谢风险增加:劳动者健康研究(ESAT)结果
Life (Basel). 2024 Sep 18;14(9):1174. doi: 10.3390/life14091174.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
3
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
4
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.按孕妇肥胖类别划分,孕期体重增加未达而非处于指南范围:产科和新生儿结局的系统评价与荟萃分析
Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18.
5
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物(二甲双胍、罗格列酮、吡格列酮、D-手性肌醇)。
Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
9
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.用于预防或治疗早期乳腺癌中芳香化酶抑制剂引起的肌肉骨骼症状的系统治疗。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD013167. doi: 10.1002/14651858.CD013167.pub2.
10
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.

引用本文的文献

1
Dynapenic abdominal obesity and the risks of heart disease and all-cause mortality: a 7-year longitudinal study among middle-aged and older Chinese adults.肌少性腹型肥胖与心脏病风险及全因死亡率:一项针对中国中老年成年人的7年纵向研究。
BMC Public Health. 2025 Jul 16;25(1):2470. doi: 10.1186/s12889-025-23664-6.
2
Correction: Carvalho et al. Increased Cardiometabolic Risk in Dynapenic Obesity: Results from the Study of Workers' Health (ESAT). 2024, , 1174.更正:卡瓦略等人。肌肉减少性肥胖中心血管代谢风险增加:工人健康研究(ESAT)的结果。2024年,,1174。
Life (Basel). 2025 Jun 4;15(6):906. doi: 10.3390/life15060906.

本文引用的文献

1
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.全球范围内 1990 年至 2022 年体重不足和肥胖趋势:对 3663 项具有 2.22 亿儿童、青少年和成年人代表性的人群研究进行的汇总分析。
Lancet. 2024 Mar 16;403(10431):1027-1050. doi: 10.1016/S0140-6736(23)02750-2. Epub 2024 Feb 29.
2
Assessment of dynapenia and undernutrition in primary care, a systematic screening study in community medicine.基层医疗中肌少症与营养不良的评估:社区医学中的系统筛查研究。
Clin Nutr ESPEN. 2023 Oct;57:561-568. doi: 10.1016/j.clnesp.2023.08.003. Epub 2023 Aug 5.
3
Lack of association between metabolic phenotype and food consumption by degree of food processing: results from the Study of Workers' Health (ESAT).
代谢表型与食物加工程度与食物摄入量之间缺乏关联:来自工人健康研究(ESAT)的结果。
Nutr Hosp. 2023 Feb 15;40(1):119-127. doi: 10.20960/nh.04242.
4
Prevalence of and risk factors for dynapenic abdominal obesity in community-dwelling older adults: a cross-sectional study.社区居住的老年人中动力性腹型肥胖的流行情况及危险因素:一项横断面研究。
Cien Saude Colet. 2022 Feb;27(2):761-769. doi: 10.1590/1413-81232022272.01122021. Epub 2021 Feb 4.
5
Cardiovascular Risk, Obesity, and Sociodemographic Indicators in a Brazilian Population.心血管风险、肥胖与巴西人群的社会人口学指标
Front Public Health. 2021 Nov 30;9:725009. doi: 10.3389/fpubh.2021.725009. eCollection 2021.
6
Validity and Reliability of IPAQ-SF and GPAQ for Assessing Sedentary Behaviour in Adults in the European Union: A Systematic Review and Meta-Analysis.《评估欧盟成年人久坐行为的 IPAQ-SF 和 GPAQ 的有效性和可靠性:系统评价和荟萃分析》
Int J Environ Res Public Health. 2021 Apr 26;18(9):4602. doi: 10.3390/ijerph18094602.
7
A nationwide study on prevalence and factors associated with dynapenia in older adults: ELSI-Brazil.一项关于老年人 dynapenia 患病率及相关因素的全国性研究:ELSIBrazil。
Cad Saude Publica. 2020 Apr 30;36(4):e00107319. doi: 10.1590/0102-311X00107319. eCollection 2020.
8
Prevalence and factors associated with sarcopenia and dynapenia in elderly people.老年人肌肉减少症和肌肉力量减退的患病率及其相关因素。
J Frailty Sarcopenia Falls. 2018 Dec 1;3(4):194-202. doi: 10.22540/JFSF-03-194. eCollection 2018 Dec.
9
The obesity transition: stages of the global epidemic.肥胖流行的转变:全球流行阶段。
Lancet Diabetes Endocrinol. 2019 Mar;7(3):231-240. doi: 10.1016/S2213-8587(19)30026-9. Epub 2019 Jan 28.
10
Sarcopenia: revised European consensus on definition and diagnosis.肌少症:定义和诊断的欧洲共识修订版。
Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.